Literature DB >> 9882291

Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber.

V Legrand1, D Spehner, Y Schlesinger, N Settelen, A Pavirani, M Mehtali.   

Abstract

In vivo targeting of therapeutic genes to specific tissues has become a major issue in gene therapy, in particular when recombinant adenovirus vectors are used. Restriction of the viral tropism to selected cell types requires the abrogation of the interaction between the viral fiber and its natural cellular receptors and the introduction of a new binding specificity into the virion. In this context, fiberless adenoviruses are attractive vectors, since they may be used as substrates for the insertion of a new ligand in other capsid proteins. In this study, we confirm by using cloned full-length adenovirus genomes with the fiber gene deleted that efficient virus particle formation can occur in the absence of fiber. As expected, the infectivity of such fiberless viruses was severely reduced, but it could be only partially restored when the viruses were produced in cells stably providing the fiber in trans. Although incorporation of penton base into the fiberless particles was normal and binding of the particles to the cellular integrins was functional, several pieces of experimental evidence suggest that later steps in the cell entry process are impaired in correlation with an incorrect maturation of several structural proteins of the fiberless particles. These observations support the hypothesis that the fiber protein may have additional biological functions besides its role in cell binding. Together with the fiber complementation cells, such fiberless vectors constitute unique tools to investigate the role of the fiber in virus assembly, maturation, and cell entry and to explore the possibility of deriving gene transfer vectors with novel target specificities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882291      PMCID: PMC103910     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

Authors:  V N Krasnykh; G V Mikheeva; J T Douglas; D T Curiel
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

2.  Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types.

Authors:  T J Wickham; P W Roelvink; D E Brough; I Kovesdi
Journal:  Nat Biotechnol       Date:  1996-11       Impact factor: 54.908

Review 3.  The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis.

Authors:  R K Assoian; E E Marcantonio
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

4.  Targeted adenovirus-mediated gene delivery to T cells via CD3.

Authors:  T J Wickham; G M Lee; J A Titus; G Sconocchia; T Bakács; I Kovesdi; D M Segal
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.

Authors:  S C Stevenson; M Rollence; J Marshall-Neff; A McClelland
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  The TMC Worldwide Gene Therapy Enrollment Report, end 1996.

Authors:  T Marcel; J D Grausz
Journal:  Hum Gene Ther       Date:  1997-04-10       Impact factor: 5.695

Review 7.  The use of adenoviral vectors for gene therapy and gene transfer in vivo.

Authors:  J L Bramson; F L Graham; J Gauldie
Journal:  Curr Opin Biotechnol       Date:  1995-10       Impact factor: 9.740

8.  Virus-receptor interaction in an adenovirus system.

Authors:  L Philipson; K Lonberg-Holm; U Pettersson
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

9.  Addition of a short peptide ligand to the adenovirus fiber protein.

Authors:  S I Michael; J S Hong; D T Curiel; J A Engler
Journal:  Gene Ther       Date:  1995-11       Impact factor: 5.250

10.  Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies.

Authors:  J C Goodman; T W Trask; S H Chen; S L Woo; R G Grossman; K D Carey; G B Hubbard; D A Carrier; S Rajagopalan; E Aguilar-Cordova; H D Shine
Journal:  Hum Gene Ther       Date:  1996-06-20       Impact factor: 5.695

View more
  29 in total

1.  Construction of a pseudoreceptor that mediates transduction by adenoviruses expressing a ligand in fiber or penton base.

Authors:  D A Einfeld; D E Brough; P W Roelvink; I Kovesdi; T J Wickham
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein.

Authors:  N Miyazawa; R G Crystal; P L Leopold
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.

Authors:  D M Shayakhmetov; T Papayannopoulou; G Stamatoyannopoulos; A Lieber
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Dependence of adenovirus infectivity on length of the fiber shaft domain.

Authors:  D M Shayakhmetov; A Lieber
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Artificial extension of the adenovirus fiber shaft inhibits infectivity in coxsackievirus and adenovirus receptor-positive cell lines.

Authors:  Toshiro Seki; Igor Dmitriev; Elena Kashentseva; Koichi Takayama; Marianne Rots; Kaori Suzuki; David T Curiel
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization.

Authors:  M Rosa-Calatrava; L Grave; F Puvion-Dutilleul; B Chatton; C Kedinger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.

Authors:  Naoya Koizumi; Hiroyuki Mizuguchi; Fuminori Sakurai; Teruhide Yamaguchi; Yoshiteru Watanabe; Takao Hayakawa
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

8.  General strategy for broadening adenovirus tropism.

Authors:  Laura Fontana; Maurizio Nuzzo; Lorena Urbanelli; Paolo Monaci
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Adenovirus protein IX sequesters host-cell promyelocytic leukaemia protein and contributes to efficient viral proliferation.

Authors:  Manuel Rosa-Calatrava; Francine Puvion-Dutilleul; Pierre Lutz; Dominique Dreyer; Hugues de Thé; Bruno Chatton; Claude Kedinger
Journal:  EMBO Rep       Date:  2003-10       Impact factor: 8.807

10.  Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells.

Authors:  D J Von Seggern; S Huang; S K Fleck; S C Stevenson; G R Nemerow
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.